You are here: Home » PTI Stories » National » News
Business Standard

Granules Hyderabad plant successfully closes USFDA inspection

Press Trust of India  |  New Delhi 

Pharma firm today said its Gagillapur facility in has completed USFDA inspection without any observations.

"The company's Gagillapur facility located in Hyderabad, .. Has successfully completed inspection without any observations," said in a filing.



"This facility manufactures finished dosages (FDs) and pharmaceutical formulation intermediates (PFIs)."

The stock of was trading 2.29 per cent higher at Rs 122.75 on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Granules Hyderabad plant successfully closes USFDA inspection

Pharma firm Granules India today said its Gagillapur facility in Hyderabad has completed USFDA inspection without any observations. "The company's Gagillapur facility located in Hyderabad, Telangana... Has successfully completed US FDA inspection without any observations," Granules India said in a BSE filing. "This facility manufactures finished dosages (FDs) and pharmaceutical formulation intermediates (PFIs)." The stock of Granules India was trading 2.29 per cent higher at Rs 122.75 on BSE. Pharma firm today said its Gagillapur facility in has completed USFDA inspection without any observations.

"The company's Gagillapur facility located in Hyderabad, .. Has successfully completed inspection without any observations," said in a filing.

"This facility manufactures finished dosages (FDs) and pharmaceutical formulation intermediates (PFIs)."

The stock of was trading 2.29 per cent higher at Rs 122.75 on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Granules Hyderabad plant successfully closes USFDA inspection

Pharma firm today said its Gagillapur facility in has completed USFDA inspection without any observations.

"The company's Gagillapur facility located in Hyderabad, .. Has successfully completed inspection without any observations," said in a filing.

"This facility manufactures finished dosages (FDs) and pharmaceutical formulation intermediates (PFIs)."

The stock of was trading 2.29 per cent higher at Rs 122.75 on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22